ORZELIA Trademark

Trademark Overview

On Tuesday, October 20, 2020, a trademark application was filed for ORZELIA with the United States Patent and Trademark Office. The USPTO has given the ORZELIA trademark a serial number of 90265564. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2024. This trademark is owned by SPERO THERAPEUTICS, INC.. The ORZELIA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, antibiotics for oral use, none being for the treatment of auto-immune diseases or rheumatoid arthritis

Pharmaceutical research services; Pharmaceutical drug development service
orzelia

General Information

Serial Number90265564
Word MarkORZELIA
Filing DateTuesday, October 20, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, antibiotics for oral use, none being for the treatment of auto-immune diseases or rheumatoid arthritis
Goods and ServicesPharmaceutical research services; Pharmaceutical drug development service

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSPERO THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameSPERO THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, October 23, 2020NEW APPLICATION ENTERED
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 20, 2021ASSIGNED TO EXAMINER
Sunday, March 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 6, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 6, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 13, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 13, 2021SOU EXTENSION 1 FILED
Monday, December 13, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 3, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, April 5, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 27, 2022NOTICE OF ALLOWANCE CORRECTION ENTERED
Thursday, April 28, 2022CORRECTED NOA E-MAILED
Friday, June 17, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 17, 2022SOU EXTENSION 2 FILED
Friday, June 17, 2022SOU EXTENSION 2 GRANTED
Tuesday, December 20, 2022SOU EXTENSION 3 GRANTED
Tuesday, June 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2022SOU EXTENSION 3 FILED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 16, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 16, 2023SOU EXTENSION 4 FILED
Friday, June 16, 2023SOU EXTENSION 4 GRANTED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 7, 2023SOU EXTENSION 5 FILED
Monday, December 18, 2023SOU EXTENSION 5 GRANTED
Monday, July 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

orzelia pharmaceutical arthritis rheumatoid research services service development drug diseases auto